Medicine and Dentistry
Case-Control Study
100%
Endoscopy
100%
COVID-19
100%
Ulcerative Colitis
100%
Rescue Therapy
30%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
Biological Product
20%
Colectomy
20%
Surgeon
10%
Ambulatory Care
10%
Secondary Care
10%
Aminosalicylic Acid Derivative
10%
Outpatient
10%
Inflammatory Bowel Disease
10%
Cyclosporine
10%
Mercaptopurine
10%
Infection
10%
Tofacitinib
10%
Laparoscopic Surgery
10%
Drug Megadose
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
100%
Case-Control Study
100%
SARS Coronavirus
37%
Pandemic
25%
Biological Product
25%
Aminosalicylic Acid
12%
Tofacitinib
12%
Infection
12%
Mercaptopurine
12%
Inflammatory Bowel Disease
12%
Ciclosporin
12%
Biochemistry, Genetics and Molecular Biology
Case-Control Study
100%
SARS Coronavirus
100%
Tofacitinib
33%
Drug Megadose
33%
Ciclosporin
33%
Mercaptopurine
33%